Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study.

Published in: Disease markers (2021)

Myocardial enzyme abnormality and myocardial injury were associated with the severity and fatal outcomes of COVID-19. Clinicians should pay attention to the markers of myocardial injury in COVID-19 patients, especially those with older age, comorbidities, and inflammation.

Keyphrases

sars cov
left ventricular
coronavirus disease
oxidative stress
working memory
physical activity
palliative care
health insurance
community dwelling
middle aged
respiratory syndrome coronavirus
heart failure
skeletal muscle
insulin resistance
weight loss